Skip to main content

Congratulations to our new PhD, Devin Effinger!

December 13, 2023
Dr. Effinger successfully defended his thesis on “Sex-Specific Effects of Psychedelic Drug Administration on Stress-Related Brain Region Reactivity and Threat Responding" Nov. 7.

Congratulations to our new PhD, Marguerite Bree Little!

December 13, 2023
Dr. LIttle successfully defended her thesis, “Determination of cross-species immune responses from outer membrane vesicle-based meningococcal vaccines to Neisseria gonorrhoeae," under the guidance of Alex Duncan, MD, PhD, on October 17.

Congratulations to our newest PhD, Amanda Graboski!

November 1, 2023
Dr. Graboski successfully defending her thesis, “Characterization and Inhibition of Gut Microbial Tryptophanase and its Implications in Chronic Kidney Disease" on September 21.

UNC Addiction Medicine Researchers Collaborate to Combat Evolving Drug Supply

July 28, 2023
Zoe McElligott, PhD, was one of three UNC addiction medicine researchers featured in Vital Signs. This translational research team is battling the opioid epidemic by analyzing the ever-changing composition of street drugs and testing how emerging drug combination such as xylazine and fentanyl interact in rodent models.

Congratulations to our new PhD, Peyton Sandroni!

June 28, 2023
Dr. Sandroni, of Brian Jensen's Lab, successfully defended his PhD thesis, "The Alpha-1A Adrenergic Receptor Regulates Oxidative Metabolism in the Mouse Heart" on June 26.

Graydon Gereau is First Author on McElligott Lab Article Published in Journal of Neurochemistry!

June 28, 2023
Congratulations to Graydon (Grey) Gereau, graduate student from the McElligott lab, on his FIRST first-author paper exploring neurotensin transmission through the brain-body connection!

Investigative team of Lindsey James; Mike Emanuele, Nick Brown, & Jon Collins win 2022-2023 Creativity Hubs Pilot Award!

June 27, 2023
The competitive award will fund their project titled, "Development of a Novel Platform Approach to Expand the Degradable Proteome." Congratulations to all!

Congratulations to our new PhD, Dr. Selin Altinok!

June 16, 2023
Dr. Altinok successfully defended her thesis “Domain-Specific Changes in CHIP Function Explain Distinct Clinical Features in SCA48 Patients” on June 6.

Bryan Roth’s Latest Venture, EvE Bio, Highlighted in Forbes

June 13, 2023
Funding from Convergent Research will support the creation of a dataset of all known interactions between small molecule drugs and drug targets, that could be used for drug repurposing or to develop effective drugs with fewer side effects. Learn more about EvE Bio.

Liz Brunk’s Jupyter Notebooks Featured in CyVerse

June 13, 2023
Liz Brunk, Ph.D., was featured in an article on CyVerse for her ground breaking development of Jupyter notebooks to facilitate learning through 3D imaging and hands-on experience.